STAGE IV MANTLE CELL LYMPHOMA
Clinical trials for STAGE IV MANTLE CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new STAGE IV MANTLE CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for STAGE IV MANTLE CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a daily pill keep mantle cell lymphoma at bay?
Disease control CompletedThis study tested whether a daily drug called ibrutinib can help prevent mantle cell lymphoma from returning after initial chemotherapy. Thirty-seven adults with the disease took ibrutinib for up to three years. Researchers tracked how long the cancer stayed away and monitored si…
Matched conditions: STAGE IV MANTLE CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC
-
New combo shows promise against tough lymphomas
Disease control CompletedThis study tested a combination of the drug lenalidomide with standard chemotherapy (EPOCH-R) in 55 people with aggressive B-cell lymphomas linked to the MYC gene. The goal was to find the safest dose and see how well the treatment controls the cancer. Results help guide future t…
Matched conditions: STAGE IV MANTLE CELL LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 15, 2026 19:01 UTC